Um, I don't think anyone on the RPRX board expected a phase III trial for Proellex in endometriosis. They were just trying to rationalize why the stock is being dumped today on reasonably good news.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.